United States Biotechnology & Medical Research

Cartesian Therapeutics, Inc. (RNAC)

Track

Track

Cartesian Therapeutics, Inc. has seen no insider trading activity within the last three months. The most recent transactions occurred in June 2026, involving proposed sales by a former affiliate. Prior historical data shows a mix of executive selling and open market buying, with the latest recorded movement dating back over ninety days.
Ticker: RNAC Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Cartesian Therapeutics, Inc.. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.2
MILOS MILJKOVIC Former Affiliate
Transaction date
Proposed sale
Price
455.52
Quantity 32,994
Value US$2,476,026
2.2
MILOS MILJKOVIC Former Affiliate
Transaction date
Proposed sale
Price
25.83
Quantity 96,165
Value US$127,551
1.9
CHRISTOPHER M JEWELL Former Affiliate
Transaction date
Proposed sale
Price
323.78
Quantity 22,935
Value US$3,356,299
1.9
CHRISTOPHER M JEWELL Former Affiliate
Transaction date
Proposed sale
Price
8.02
Quantity 1,510
Value US$12,105
3.7
Brunn Carsten President and CEO Executive Director
Transaction date
Sale
Price
6.82
Quantity 23,766 -6.8%
Value US$162,077
2.2
Miljkovic Milos Chief Medical Officer Officer
Transaction date
Sale
Price
6.82
Quantity 3,573 -5.7%
Value US$24,367
3.2
Davis Blaine Chief Financial Officer Officer
Transaction date
Sale
Price
6.82
Quantity 10,591 -8.0%
Value US$72,227
2.3
BARABE TIMOTHY C Non-Executive Director
Transaction date
Purchase
Price
6.86
Quantity 30,000 +123.1%
Value US$205,797
1.9
CHRISTOPHER M JEWELL Former Affiliate
Transaction date
Proposed sale
Price
7.15
Quantity 26,935
Value US$192,585
3.4
SPRINGER TIMOTHY A Non-Executive Director Large shareholder
Transaction date
Purchase
Price
10.77
Quantity 36,338 +5.9%
Value US$391,455
3.4
SPRINGER TIMOTHY A Non-Executive Director Large shareholder
Transaction date
Purchase
Price
10.77
Quantity 6,412 +0.1%
Value US$69,074
3.4
SPRINGER TIMOTHY A Non-Executive Director Large shareholder
Transaction date
Purchase
Price
10.92
Quantity 3,451 +0.6%
Value US$37,696
3.4
SPRINGER TIMOTHY A Non-Executive Director Large shareholder
Transaction date
Purchase
Price
10.43
Quantity 45,144 +7.9%
Value US$471,055
3.4
SPRINGER TIMOTHY A Non-Executive Director Large shareholder
Transaction date
Purchase
Price
10.92
Quantity 609 +0.0%
Value US$6,652
3.4
SPRINGER TIMOTHY A Non-Executive Director Large shareholder
Transaction date
Purchase
Price
10.43
Quantity 7,966 +0.1%
Value US$83,121
3.4
SPRINGER TIMOTHY A Non-Executive Director Large shareholder
Transaction date
Purchase
Price
9.95
Quantity 178 +0.0%
Value US$1,771
3.4
SPRINGER TIMOTHY A Non-Executive Director Large shareholder
Transaction date
Purchase
Price
9.43
Quantity 41,604 +7.9%
Value US$392,176
3.4
SPRINGER TIMOTHY A Non-Executive Director Large shareholder
Transaction date
Purchase
Price
9.95
Quantity 31 +0.0%
Value US$308
3.4
SPRINGER TIMOTHY A Non-Executive Director Large shareholder
Transaction date
Purchase
Price
9.43
Quantity 7,342 +0.1%
Value US$69,209
3.4
SPRINGER TIMOTHY A Non-Executive Director Large shareholder
Transaction date
Purchase
Price
15.59
Quantity 54,889 +0.6%
Value US$855,593
3.4
SPRINGER TIMOTHY A Non-Executive Director Large shareholder
Transaction date
Purchase
Price
14.97
Quantity 20,234 +0.2%
Value US$302,962
3.4
SPRINGER TIMOTHY A Non-Executive Director Large shareholder
Transaction date
Purchase
Price
14.42
Quantity 14,740 +0.2%
Value US$212,599
3.4
SPRINGER TIMOTHY A Non-Executive Director Large shareholder
Transaction date
Purchase
Price
18.00
Quantity 4,022 +0.0%
Value US$72,396
3.4
SPRINGER TIMOTHY A Non-Executive Director Large shareholder
Transaction date
Purchase
Price
17.78
Quantity 8,983 +0.1%
Value US$159,738
3.4
SPRINGER TIMOTHY A Non-Executive Director Large shareholder
Transaction date
Purchase
Price
16.86
Quantity 7,962 +0.1%
Value US$134,220
2.7
Kurtoglu Metin Chief Technology Officer Officer
Transaction date
Sale
Price
16.83
Quantity 2,458 -3.8%
Value US$41,374
3.2
Davis Blaine Chief Financial Officer Officer
Transaction date
Sale
Price
16.83
Quantity 4,028 -4.1%
Value US$67,800
2.2
Miljkovic Milos Chief Medical Officer Officer
Transaction date
Sale
Price
16.83
Quantity 948 -2.6%
Value US$15,957
1.9
Jewell Christopher M Chief Scientific Officer Officer
Transaction date
Sale
Price
16.83
Quantity 1,286 -2.3%
Value US$21,646
3.7
Brunn Carsten President and CEO Executive Director
Transaction date
Sale
Price
16.83
Quantity 8,708 -4.1%
Value US$146,575
2.7
English Emily Chief Operations Officer Officer
Transaction date
Sale
Price
16.83
Quantity 906 -2.2%
Value US$15,250
2.7
Kurtoglu Metin Chief Technology Officer Officer
Transaction date
Sale
Price
16.72
Quantity 2,417 -3.6%
Value US$40,417
3.2
Davis Blaine Chief Financial Officer Officer
Transaction date
Sale
Price
16.72
Quantity 3,961 -3.9%
Value US$66,235
2.2
Miljkovic Milos Chief Medical Officer Officer
Transaction date
Sale
Price
16.72
Quantity 932 -2.5%
Value US$15,585
1.9
Jewell Christopher M Chief Scientific Officer Officer
Transaction date
Sale
Price
16.72
Quantity 1,264 -2.3%
Value US$21,136
3.7
Brunn Carsten President and CEO Executive Director
Transaction date
Sale
Price
16.72
Quantity 8,563 -3.9%
Value US$143,190
2.7
English Emily Chief Operations Officer Officer
Transaction date
Sale
Price
16.72
Quantity 891 -2.1%
Value US$14,899
3.4
SPRINGER TIMOTHY A Non-Executive Director Large shareholder
Transaction date
Purchase
Price
19.00
Quantity 5,181 +0.1%
Value US$98,437
3.4
SPRINGER TIMOTHY A Non-Executive Director Large shareholder
Transaction date
Purchase
Price
18.94
Quantity 21,800 +0.3%
Value US$412,968
3.4
SPRINGER TIMOTHY A Non-Executive Director Large shareholder
Transaction date
Purchase
Price
18.93
Quantity 3,376 +0.0%
Value US$63,901
3.4
SPRINGER TIMOTHY A Non-Executive Director Large shareholder
Transaction date
Purchase
Price
18.35
Quantity 10,529 +0.1%
Value US$193,203
3.4
SPRINGER TIMOTHY A Non-Executive Director Large shareholder
Transaction date
Purchase
Price
17.39
Quantity 11,303 +0.1%
Value US$196,512
2.7
Kurtoglu Metin Chief Technology Officer Officer
Transaction date
Sale
Price
24.35
Quantity 2,901 -5.4%
Value US$70,640
2.7
METIN KURTOGLU Officer Officer
Transaction date
Proposed sale
Price
24.35
Quantity 2,901
Value US$70,640
2.7
Kurtoglu Metin Chief Technology Officer Officer
Transaction date
Sale
Price
25.83
Quantity 4,539 -8.2%
Value US$117,257
2.7
Kurtoglu Metin Chief Technology Officer Officer
Transaction date
Sale
Price
25.26
Quantity 6,224 -10.1%
Value US$157,236
2.7
METIN KURTOGLU Officer Officer
Transaction date
Proposed sale
Price
25.50
Quantity 10,763
Value US$274,493
2.7
METIN KURTOGLU Officer Officer
Transaction date
Proposed sale
Price
16.67
Quantity 32,789
Value US$546,560
2.7
Kurtoglu Metin Chief Technology Officer Officer
Transaction date
Sale
Price
16.67
Quantity 32,789 -39.1%
Value US$546,560
2.7
Kurtoglu Metin Chief Technology Officer Officer
Transaction date
Sale
Price
18.09
Quantity 100 -0.2%
Value US$1,809
2.7
Kurtoglu Metin Chief Technology Officer Officer
Transaction date
Sale
Price
17.28
Quantity 5,600 -9.9%
Value US$96,761
2.7
METIN KURTOGLU Officer Officer
Transaction date
Proposed sale
Price
17.29
Quantity 5,700
Value US$98,570
2.7
Kurtoglu Metin Chief Technology Officer Officer
Transaction date
Sale
Price
19.50
Quantity 200 -0.4%
Value US$3,900
2.7
METIN KURTOGLU Officer Officer
Transaction date
Proposed sale
Price
19.50
Quantity 200
Value US$3,900
2.7
METIN KURTOGLU Officer Officer
Transaction date
Proposed sale
Price
18.39
Quantity 34,400
Value US$632,640
2.7
Kurtoglu Metin Chief Technology Officer Officer
Transaction date
Sale
Price
18.58
Quantity 17,728 -25.8%
Value US$329,429
2.7
Kurtoglu Metin Chief Technology Officer Officer
Transaction date
Sale
Price
18.19
Quantity 16,672 -19.5%
Value US$303,212
3.4
SPRINGER TIMOTHY A Non-Executive Director Large shareholder
Transaction date
Purchase
Price
18.42
Quantity 20,181 +0.2%
Value US$371,736
3.4
SPRINGER TIMOTHY A Non-Executive Director Large shareholder
Transaction date
Purchase
Price
17.96
Quantity 38,114 +0.5%
Value US$684,447
2.2
Miljkovic Milos Chief Medical Officer Officer
Transaction date
Sale
Price
17.14
Quantity 20,000 -52.3%
Value US$342,888
2.7
Kurtoglu Metin Chief Technology Officer Officer
Transaction date
Sale
Price
17.20
Quantity 22,068 -30.2%
Value US$379,497
1.9
Jewell Christopher M Chief Scientific Officer Officer
Transaction date
Sale
Price
17.06
Quantity 16,065 -38.2%
Value US$274,093
3.4
SPRINGER TIMOTHY A Non-Executive Director Large shareholder
Transaction date
Purchase
Price
17.09
Quantity 277,246 +3.4%
Value US$4,739,188
2.7
METIN KURTOGLU Officer Officer
Transaction date
Proposed sale
Price
17.20
Quantity 22,068
Value US$379,497
1.9
CHRISTOPHER M JEWELL Officer Officer
Transaction date
Proposed sale
Price
17.06
Quantity 16,065
Value US$274,093
2.2
MILOS MILJKOVIC Officer Officer
Transaction date
Proposed sale
Price
17.14
Quantity 20,000
Value US$342,889
2.2
Miljkovic Milos Chief Medical Officer Officer
Transaction date
Sale
Price
16.13
Quantity 35,000 -65.7%
Value US$564,644
2.7
Kurtoglu Metin Chief Technology Officer Officer
Transaction date
Sale
Price
17.06
Quantity 4,000 -7.3%
Value US$68,256
2.7
Kurtoglu Metin Chief Technology Officer Officer
Transaction date
Sale
Price
16.33
Quantity 21,900 -28.5%
Value US$357,645
1.9
Jewell Christopher M Chief Scientific Officer Officer
Transaction date
Sale
Price
17.02
Quantity 17,500 -40.3%
Value US$297,824
1.9
Jewell Christopher M Chief Scientific Officer Officer
Transaction date
Sale
Price
16.34
Quantity 18,550 -29.9%
Value US$303,126
3.4
SPRINGER TIMOTHY A Non-Executive Director Large shareholder
Transaction date
Purchase
Price
16.97
Quantity 22,242 +0.3%
Value US$377,436
3.4
SPRINGER TIMOTHY A Non-Executive Director Large shareholder
Transaction date
Purchase
Price
16.19
Quantity 74,157 +0.9%
Value US$1,200,720
2.7
METIN KURTOGLU Officer Officer
Transaction date
Proposed sale
Price
16.44
Quantity 25,900
Value US$425,900
1.9
CHRISTOPHER M JEWELL Officer Officer
Transaction date
Proposed sale
Price
16.67
Quantity 36,050
Value US$600,949
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-09 2026-06-09 PrS Proposed sale
2.2
MILOS MILJKOVIC

Former Affiliate
32,994
455.52
US$2,476,026 		32,994 455.52 US$2,476,026
2026-06-02 2026-06-02 PrS Proposed sale
2.2
MILOS MILJKOVIC

Former Affiliate
96,165
25.83
US$127,551 		96,165 25.83 US$127,551
2026-01-13 2026-01-13 PrS Proposed sale
1.9
CHRISTOPHER M JEWELL

Former Affiliate
22,935
323.78
US$3,356,299 		22,935 323.78 US$3,356,299
2026-01-09 2026-01-09 PrS Proposed sale
1.9
CHRISTOPHER M JEWELL

Former Affiliate
1,510
8.02
US$12,105 		1,510 8.02 US$12,105
2026-01-08 2026-01-06 S Sale
3.7
Brunn Carsten

President and CEO

Executive Director
23,766 -6.8%
6.82
US$162,077 		23,766 -6.8% 6.82 US$162,077
2026-01-08 2026-01-06 S Sale
2.2
Miljkovic Milos

Chief Medical Officer

Officer
3,573 -5.7%
6.82
US$24,367 		3,573 -5.7% 6.82 US$24,367
2026-01-08 2026-01-06 S Sale
3.2
Davis Blaine

Chief Financial Officer

Officer
10,591 -8.0%
6.82
US$72,227 		10,591 -8.0% 6.82 US$72,227
2025-12-08 2025-12-04 B Purchase
2.3
BARABE TIMOTHY C
Non-Executive Director
30,000 +123.1%
6.86
US$205,797 		30,000 +123.1% 6.86 US$205,797
2025-11-19 2025-11-19 PrS Proposed sale
1.9
CHRISTOPHER M JEWELL

Former Affiliate
26,935
7.15
US$192,585 		26,935 7.15 US$192,585
2025-04-11 2025-04-11 B Purchase
3.4
SPRINGER TIMOTHY A
Non-Executive Director Large shareholder
36,338 +5.9%
10.77
US$391,455 		36,338 +5.9% 10.77 US$391,455
2025-04-11 2025-04-11 B Purchase
3.4
SPRINGER TIMOTHY A
Non-Executive Director Large shareholder
6,412 +0.1%
10.77
US$69,074 		6,412 +0.1% 10.77 US$69,074
2025-04-11 2025-04-10 B Purchase
3.4
SPRINGER TIMOTHY A
Non-Executive Director Large shareholder
3,451 +0.6%
10.92
US$37,696 		3,451 +0.6% 10.92 US$37,696
2025-04-11 2025-04-10 B Purchase
3.4
SPRINGER TIMOTHY A
Non-Executive Director Large shareholder
45,144 +7.9%
10.43
US$471,055 		45,144 +7.9% 10.43 US$471,055
2025-04-11 2025-04-10 B Purchase
3.4
SPRINGER TIMOTHY A
Non-Executive Director Large shareholder
609 +0.0%
10.92
US$6,652 		609 +0.0% 10.92 US$6,652
2025-04-11 2025-04-10 B Purchase
3.4
SPRINGER TIMOTHY A
Non-Executive Director Large shareholder
7,966 +0.1%
10.43
US$83,121 		7,966 +0.1% 10.43 US$83,121
2025-04-11 2025-04-09 B Purchase
3.4
SPRINGER TIMOTHY A
Non-Executive Director Large shareholder
178 +0.0%
9.95
US$1,771 		178 +0.0% 9.95 US$1,771
2025-04-11 2025-04-09 B Purchase
3.4
SPRINGER TIMOTHY A
Non-Executive Director Large shareholder
41,604 +7.9%
9.43
US$392,176 		41,604 +7.9% 9.43 US$392,176
2025-04-11 2025-04-09 B Purchase
3.4
SPRINGER TIMOTHY A
Non-Executive Director Large shareholder
31 +0.0%
9.95
US$308 		31 +0.0% 9.95 US$308
2025-04-11 2025-04-09 B Purchase
3.4
SPRINGER TIMOTHY A
Non-Executive Director Large shareholder
7,342 +0.1%
9.43
US$69,209 		7,342 +0.1% 9.43 US$69,209
2025-03-20 2025-03-20 B Purchase
3.4
SPRINGER TIMOTHY A
Non-Executive Director Large shareholder
54,889 +0.6%
15.59
US$855,593 		54,889 +0.6% 15.59 US$855,593
2025-03-20 2025-03-19 B Purchase
3.4
SPRINGER TIMOTHY A
Non-Executive Director Large shareholder
20,234 +0.2%
14.97
US$302,962 		20,234 +0.2% 14.97 US$302,962
2025-03-20 2025-03-18 B Purchase
3.4
SPRINGER TIMOTHY A
Non-Executive Director Large shareholder
14,740 +0.2%
14.42
US$212,599 		14,740 +0.2% 14.42 US$212,599
2025-01-15 2025-01-14 B Purchase
3.4
SPRINGER TIMOTHY A
Non-Executive Director Large shareholder
4,022 +0.0%
18.00
US$72,396 		4,022 +0.0% 18.00 US$72,396
2025-01-15 2025-01-13 B Purchase
3.4
SPRINGER TIMOTHY A
Non-Executive Director Large shareholder
8,983 +0.1%
17.78
US$159,738 		8,983 +0.1% 17.78 US$159,738
2025-01-15 2025-01-13 B Purchase
3.4
SPRINGER TIMOTHY A
Non-Executive Director Large shareholder
7,962 +0.1%
16.86
US$134,220 		7,962 +0.1% 16.86 US$134,220
2025-01-07 2025-01-06 S Sale
2.7
Kurtoglu Metin

Chief Technology Officer

Officer
2,458 -3.8%
16.83
US$41,374 		2,458 -3.8% 16.83 US$41,374
2025-01-07 2025-01-06 S Sale
3.2
Davis Blaine

Chief Financial Officer

Officer
4,028 -4.1%
16.83
US$67,800 		4,028 -4.1% 16.83 US$67,800
2025-01-07 2025-01-06 S Sale
2.2
Miljkovic Milos

Chief Medical Officer

Officer
948 -2.6%
16.83
US$15,957 		948 -2.6% 16.83 US$15,957
2025-01-07 2025-01-06 S Sale
1.9
Jewell Christopher M

Chief Scientific Officer

Officer
1,286 -2.3%
16.83
US$21,646 		1,286 -2.3% 16.83 US$21,646
2025-01-07 2025-01-06 S Sale
3.7
Brunn Carsten

President and CEO

Executive Director
8,708 -4.1%
16.83
US$146,575 		8,708 -4.1% 16.83 US$146,575
2025-01-07 2025-01-06 S Sale
2.7
English Emily

Chief Operations Officer

Officer
906 -2.2%
16.83
US$15,250 		906 -2.2% 16.83 US$15,250
2025-01-07 2025-01-03 S Sale
2.7
Kurtoglu Metin

Chief Technology Officer

Officer
2,417 -3.6%
16.72
US$40,417 		2,417 -3.6% 16.72 US$40,417
2025-01-07 2025-01-03 S Sale
3.2
Davis Blaine

Chief Financial Officer

Officer
3,961 -3.9%
16.72
US$66,235 		3,961 -3.9% 16.72 US$66,235
2025-01-07 2025-01-03 S Sale
2.2
Miljkovic Milos

Chief Medical Officer

Officer
932 -2.5%
16.72
US$15,585 		932 -2.5% 16.72 US$15,585
2025-01-07 2025-01-03 S Sale
1.9
Jewell Christopher M

Chief Scientific Officer

Officer
1,264 -2.3%
16.72
US$21,136 		1,264 -2.3% 16.72 US$21,136
2025-01-07 2025-01-03 S Sale
3.7
Brunn Carsten

President and CEO

Executive Director
8,563 -3.9%
16.72
US$143,190 		8,563 -3.9% 16.72 US$143,190
2025-01-07 2025-01-03 S Sale
2.7
English Emily

Chief Operations Officer

Officer
891 -2.1%
16.72
US$14,899 		891 -2.1% 16.72 US$14,899
2024-12-23 2024-12-23 B Purchase
3.4
SPRINGER TIMOTHY A
Non-Executive Director Large shareholder
5,181 +0.1%
19.00
US$98,437 		5,181 +0.1% 19.00 US$98,437
2024-12-23 2024-12-20 B Purchase
3.4
SPRINGER TIMOTHY A
Non-Executive Director Large shareholder
21,800 +0.3%
18.94
US$412,968 		21,800 +0.3% 18.94 US$412,968
2024-12-23 2024-12-19 B Purchase
3.4
SPRINGER TIMOTHY A
Non-Executive Director Large shareholder
3,376 +0.0%
18.93
US$63,901 		3,376 +0.0% 18.93 US$63,901
2024-12-23 2024-12-19 B Purchase
3.4
SPRINGER TIMOTHY A
Non-Executive Director Large shareholder
10,529 +0.1%
18.35
US$193,203 		10,529 +0.1% 18.35 US$193,203
2024-12-23 2024-12-19 B Purchase
3.4
SPRINGER TIMOTHY A
Non-Executive Director Large shareholder
11,303 +0.1%
17.39
US$196,512 		11,303 +0.1% 17.39 US$196,512
2024-12-11 2024-12-10 S Sale
2.7
Kurtoglu Metin

Chief Technology Officer

Officer
2,901 -5.4%
24.35
US$70,640 		2,901 -5.4% 24.35 US$70,640
2024-12-10 2024-12-10 PrS Proposed sale
2.7
METIN KURTOGLU

Officer

Officer
2,901
24.35
US$70,640 		2,901 24.35 US$70,640
2024-12-11 2024-12-09 S Sale
2.7
Kurtoglu Metin

Chief Technology Officer

Officer
4,539 -8.2%
25.83
US$117,257 		4,539 -8.2% 25.83 US$117,257
2024-12-11 2024-12-09 S Sale
2.7
Kurtoglu Metin

Chief Technology Officer

Officer
6,224 -10.1%
25.26
US$157,236 		6,224 -10.1% 25.26 US$157,236
2024-12-09 2024-12-09 PrS Proposed sale
2.7
METIN KURTOGLU

Officer

Officer
10,763
25.50
US$274,493 		10,763 25.50 US$274,493
2024-11-21 2024-11-21 PrS Proposed sale
2.7
METIN KURTOGLU

Officer

Officer
32,789
16.67
US$546,560 		32,789 16.67 US$546,560
2024-11-21 2024-11-21 S Sale
2.7
Kurtoglu Metin

Chief Technology Officer

Officer
32,789 -39.1%
16.67
US$546,560 		32,789 -39.1% 16.67 US$546,560
2024-11-21 2024-11-20 S Sale
2.7
Kurtoglu Metin

Chief Technology Officer

Officer
100 -0.2%
18.09
US$1,809 		100 -0.2% 18.09 US$1,809
2024-11-21 2024-11-20 S Sale
2.7
Kurtoglu Metin

Chief Technology Officer

Officer
5,600 -9.9%
17.28
US$96,761 		5,600 -9.9% 17.28 US$96,761
2024-11-20 2024-11-20 PrS Proposed sale
2.7
METIN KURTOGLU

Officer

Officer
5,700
17.29
US$98,570 		5,700 17.29 US$98,570
2024-11-21 2024-11-19 S Sale
2.7
Kurtoglu Metin

Chief Technology Officer

Officer
200 -0.4%
19.50
US$3,900 		200 -0.4% 19.50 US$3,900
2024-11-19 2024-11-19 PrS Proposed sale
2.7
METIN KURTOGLU

Officer

Officer
200
19.50
US$3,900 		200 19.50 US$3,900
2024-11-18 2024-11-18 PrS Proposed sale
2.7
METIN KURTOGLU

Officer

Officer
34,400
18.39
US$632,640 		34,400 18.39 US$632,640
2024-11-18 2024-11-18 S Sale
2.7
Kurtoglu Metin

Chief Technology Officer

Officer
17,728 -25.8%
18.58
US$329,429 		17,728 -25.8% 18.58 US$329,429
2024-11-18 2024-11-18 S Sale
2.7
Kurtoglu Metin

Chief Technology Officer

Officer
16,672 -19.5%
18.19
US$303,212 		16,672 -19.5% 18.19 US$303,212
2024-11-18 2024-11-18 B Purchase
3.4
SPRINGER TIMOTHY A
Non-Executive Director Large shareholder
20,181 +0.2%
18.42
US$371,736 		20,181 +0.2% 18.42 US$371,736
2024-11-18 2024-11-18 B Purchase
3.4
SPRINGER TIMOTHY A
Non-Executive Director Large shareholder
38,114 +0.5%
17.96
US$684,447 		38,114 +0.5% 17.96 US$684,447
2024-11-18 2024-11-15 S Sale
2.2
Miljkovic Milos

Chief Medical Officer

Officer
20,000 -52.3%
17.14
US$342,888 		20,000 -52.3% 17.14 US$342,888
2024-11-18 2024-11-15 S Sale
2.7
Kurtoglu Metin

Chief Technology Officer

Officer
22,068 -30.2%
17.20
US$379,497 		22,068 -30.2% 17.20 US$379,497
2024-11-18 2024-11-15 S Sale
1.9
Jewell Christopher M

Chief Scientific Officer

Officer
16,065 -38.2%
17.06
US$274,093 		16,065 -38.2% 17.06 US$274,093
2024-11-18 2024-11-15 B Purchase
3.4
SPRINGER TIMOTHY A
Non-Executive Director Large shareholder
277,246 +3.4%
17.09
US$4,739,188 		277,246 +3.4% 17.09 US$4,739,188
2024-11-15 2024-11-15 PrS Proposed sale
2.7
METIN KURTOGLU

Officer

Officer
22,068
17.20
US$379,497 		22,068 17.20 US$379,497
2024-11-15 2024-11-15 PrS Proposed sale
1.9
CHRISTOPHER M JEWELL

Officer

Officer
16,065
17.06
US$274,093 		16,065 17.06 US$274,093
2024-11-15 2024-11-15 PrS Proposed sale
2.2
MILOS MILJKOVIC

Officer

Officer
20,000
17.14
US$342,889 		20,000 17.14 US$342,889
2024-11-18 2024-11-14 S Sale
2.2
Miljkovic Milos

Chief Medical Officer

Officer
35,000 -65.7%
16.13
US$564,644 		35,000 -65.7% 16.13 US$564,644
2024-11-18 2024-11-14 S Sale
2.7
Kurtoglu Metin

Chief Technology Officer

Officer
4,000 -7.3%
17.06
US$68,256 		4,000 -7.3% 17.06 US$68,256
2024-11-18 2024-11-14 S Sale
2.7
Kurtoglu Metin

Chief Technology Officer

Officer
21,900 -28.5%
16.33
US$357,645 		21,900 -28.5% 16.33 US$357,645
2024-11-18 2024-11-14 S Sale
1.9
Jewell Christopher M

Chief Scientific Officer

Officer
17,500 -40.3%
17.02
US$297,824 		17,500 -40.3% 17.02 US$297,824
2024-11-18 2024-11-14 S Sale
1.9
Jewell Christopher M

Chief Scientific Officer

Officer
18,550 -29.9%
16.34
US$303,126 		18,550 -29.9% 16.34 US$303,126
2024-11-18 2024-11-14 B Purchase
3.4
SPRINGER TIMOTHY A
Non-Executive Director Large shareholder
22,242 +0.3%
16.97
US$377,436 		22,242 +0.3% 16.97 US$377,436
2024-11-18 2024-11-14 B Purchase
3.4
SPRINGER TIMOTHY A
Non-Executive Director Large shareholder
74,157 +0.9%
16.19
US$1,200,720 		74,157 +0.9% 16.19 US$1,200,720
2024-11-14 2024-11-14 PrS Proposed sale
2.7
METIN KURTOGLU

Officer

Officer
25,900
16.44
US$425,900 		25,900 16.44 US$425,900
2024-11-14 2024-11-14 PrS Proposed sale
1.9
CHRISTOPHER M JEWELL

Officer

Officer
36,050
16.67
US$600,949 		36,050 16.67 US$600,949
Explore more

More insider trading research around Cartesian Therapeutics, Inc.

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America